Nimodipine binding in focal cerebral ischemia

Area of Science:

• Neuroscience
• Pharmacology
• Ischemic Stroke Research

Background:

• Focal cerebral ischemia triggers complex cellular events, including alterations in ion channel activity.
• Voltage-sensitive calcium channels play a critical role in neuronal damage during ischemic conditions.
• Nimodipine, a dihydropyridine calcium channel antagonist, has neuroprotective properties that warrant further investigation in ischemic models.

Purpose of the Study:

• To investigate the binding characteristics of nimodipine in a rat model of focal cerebral ischemia.
• To determine the relationship between nimodipine binding and the severity and duration of cerebral ischemia.
• To explore the potential of nimodipine binding as a biomarker for identifying and monitoring ischemic brain tissue.

Main Methods:

• Induction of focal cerebral ischemia in male Sprague-Dawley rats via middle cerebral artery and common carotid artery occlusion.
• Intravenous infusion of radiolabeled 3H-nimodipine.
• Post-mortem brain tissue analysis using quantitative autoradiography at various time points (5 minutes, 4, 24, and 48 hours) after occlusion.

Main Results:

• A focal increase in nimodipine binding was observed in severely ischemic brain regions as early as 5 minutes post-occlusion.
• Increased nimodipine binding extended to regions with presumed penumbral blood flow at 4 hours after occlusion.
• The extent of nimodipine binding correlated with the duration and severity of the induced cerebral ischemia.

Conclusions:

• Nimodipine binding appears to be localized to activated calcium channels within ischemic brain tissue.
• Sequential monitoring of nimodipine binding could serve as a tool to identify potentially reversible ischemic damage.
• This approach may facilitate the assessment of therapeutic interventions aimed at mitigating ischemic injury.